EFFICACY OF PROBIOTICS ON THE COGNITIVE FUNCTION, SLEEP EFFICIENCY, AND ANTIOXIDATIVE BIOMARKERS IN PATIENTS WITH ALZHEIMER'S DISEASE DEMENTIA: A 12-WEEK RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP CLINICAL TRIAL

被引:0
|
作者
Sun, Y. [1 ,2 ]
Kuo, Y. -W. [3 ]
Tsai, S. -Y. [3 ]
Lin, J. -H. [3 ]
Hsu, Y. -C. [3 ]
Chen, J. -F. [3 ]
Hsia, K. -C. [3 ]
Ho, H. -H. [3 ]
Liu, H. -H. [4 ,5 ]
Kua, H. -C. [5 ]
机构
[1] En Chu Kong Hosp, Neurol, New Taipei, Taiwan
[2] Natl Taiwan Univ, Coll Med, Neurol, Taipei, Taiwan
[3] Glac Biotech Co Ltd, Res & Design, Tainan, Taiwan
[4] Natl Hlth Res Inst, Mol & Genom Med, Zhunan Township, Miaoli County, Taiwan
[5] En Chu Kong Hosp, Pediat, New Taipei, Taiwan
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:234 / 234
页数:1
相关论文
共 50 条
  • [41] Analgesic effectiveness of celecoxib and diclofenac in patients with osteoarthritis of the hip requiring joint replacement surgery: a 12-week, multicenter, randomized, double-blind, parallel-group, double-dummy, noninferiority study
    Emery, Paul
    Koncz, Tamas
    Pan, Sharon
    Lowry, Simon
    CLINICAL THERAPEUTICS, 2008, 30 (01) : 70 - 83
  • [42] Effectiveness of Partially Hydrolyzed Guar Gum on Cognitive Function and Sleep Efficiency in Healthy Elderly Subjects in a Randomized, Double-Blind, Placebo-Controlled, and Parallel-Group Study
    Abe, Aya
    Kapoor, Mahendra Parkash
    Morishima, So
    Ozeki, Makoto
    Sato, Norio
    Takara, Tsuyoshi
    Naito, Yuji
    NUTRIENTS, 2024, 16 (08)
  • [43] Remifentanil versus Fentanyl for Analgesia in Mechanically Ventilated Patients: A Multicenter, Prospective, Randomized, Double-Blind, Parallel-Group Clinical Trial
    Li, Cong
    Gao, Zhiwei
    Chen, Hui
    Hu, Linlin
    Ma, Shaolei
    Zhang, Junwei
    Chen, Dongyu
    Xie, Jianfeng
    Pan, Chun
    Yang, Yi
    Liu, Ling
    ALTERNATIVE THERAPIES IN HEALTH AND MEDICINE, 2023, 29 (07) : 138 - 147
  • [44] Comment on "Efficacy and safety of a transdermal donepezil patch in patients with mild-to-moderate Alzheimer's disease: A 24-week, randomized, multicenter, double-blind, parallel-group, non-inferiority study"
    Mutlay, Feyza
    Kaya, Derya
    Isik, Ahmet Turan
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2023, 23 (07) : 582 - 583
  • [45] Evaluation of pulsing magnetic field effects on paresthesia in multiple sclerosis patients, a randomized, double-blind, parallel-group clinical trial
    Afshari, Daryoush
    Moradian, Nasrin
    Khalili, Majid
    Razazian, Nazanin
    Bostani, Arash
    Hoseini, Jamal
    Moradian, Mohamad
    Ghiasian, Masoud
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2016, 149 : 171 - 174
  • [46] A randomized, double-blind, placebo-controlled clinical trial to evaluate pregabalin efficacy in the treatment of behavioral and psychological symptoms of dementia in patients with Alzheimer's disease
    Maleki, Leyla
    Mohammadian, Fatemeh
    Panahishokouh, Mahsa
    Mohebbi, Niayesh
    FRONTIERS IN NEUROSCIENCE, 2024, 18
  • [47] Efficacy and safety of inhaled nitrite in addition to sildenafil in thalassemia patients with pulmonary hypertension: A 12-week randomized, double-blind placebo-controlled clinical trial
    Sasiprapha, Thinnakrit
    Pussadhamma, Burabha
    Sibmooh, Nathawut
    Sriwantana, Thanaporn
    Pienvichit, Pavit
    Chuncharunee, Suporn
    Yingchoncharoen, Teerapat
    NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2022, 120 : 38 - 43
  • [48] Sustained-release versus immediate-release glipizide for treatment of type 2 diabetes mellitus in Chinese patients: A randomized, double-blind, double-dummy, parallel-group, 12-week clinical study
    Hsieh, Sheng-Hwu
    Lin, Jen-Der
    Chang, Hung-Yu
    Ho, Cheng
    Liou, Miaw-Jene
    CLINICAL THERAPEUTICS, 2006, 28 (09) : 1318 - 1326
  • [49] Combination therapy with liraglutide and insulin in Japanese patients with type 2 diabetes: A 36-week, randomized, double-blind, parallel-group trial
    Seino, Yutaka
    Kaneko, Shizuka
    Fukuda, Shuichi
    Osonoi, Takeshi
    Shiraiwa, Toshihiko
    Nishijima, Keiji
    Bosch-Traberg, Heidrun
    Kaku, Kohei
    JOURNAL OF DIABETES INVESTIGATION, 2016, 7 (04) : 565 - 573
  • [50] The effects of empagliflozin in patients with type 1 diabetes: Results of a 12-week, double-blind, randomized, placebo-controlled clinical trial
    Najafipour, Mostafa
    Najafipour, Farzad
    Ostadrahimi, Alireza
    Ghavami, Maryam
    Razaghi, Zohreh
    Tutunchi, Helda
    Alamdari, Naimeh Mesri
    HEALTH PROMOTION PERSPECTIVES, 2024, 14 (04): : 380 - 387